Veinlite PEDI® Proven Effective in Randomized Controlled Trial

Tuesday, October 2, 2018 Child Health News
Email Print This Page Comment bookmark
Font : A-A+

TransLite LLC's Veinlite PEDI® Improved Vein Access in Children from 72.2% Success Rate to 92.9%

SUGAR LAND, Texas, Oct. 02, 2018 /PRNewswire-PRWeb/ -- In a recently published randomized controlled study, TransLite's

Veinlite PEDI® was compared to the Standard of Care for peripheral IV access. The use of Veinlite PEDI® was found to deliver superior results in all key performance indicators, including first time IV access success rate, required number of attempts, and total time of attempts.

The clinical study was completed by Merve Gümü?, RN, MSc and Zümrüt Ba?bakkal, PhD, on a sample of 110 pediatric patients (58 boys and 52 girls), between the ages of 1 and 10. PIC intervention is widely regarded to be a challenging task, especially among children, who have smaller blood vessels, more adipose tissue, and are more difficult to communicate with.

The conclusion states, "The use of new technology in the Veinlite PEDI to assist with peripheral IV access in children improves the first time success rate for IV access. These results suggest that the new technology of the Veinlite results in better PIC access."

Notable Results:

  • First attempt success rate of 92.9% using Veinlite PEDI compared with 72.7% for Standard of Care
  • Veinlite group had fewer number of attempts compared to Standard of Care
  • Veinlite group resulted in shorter total time of attempts per patient compared to Standard of Care

These results demonstrate the efficacy of Veinlite PEDI® in improving patient satisfaction and enabling medical professionals to be more effective in the process.

Veinlite PEDI is a compact, portable vein access device featuring red and orange lights that can be used in side-transillumination or through-the-body visualization. It can be used anywhere on the body, including the scalp.

Veinlite PEDI also meets INS Guidelines for infection control, a critical consideration when providing healthcare treatment to any patient. Veinlite PEDI is available immediately. US customers can purchase direct from the company's website, veinlite.com (includes an exclusive five-year extended warranty). For customers in other countries and territories, please see Veinlite's Authorized International Distributors.

To learn more about Veinlite PEDI® – or TransLite's complete line of IV access and Sclerotherapy vein finders – visit https://www.veinlite.com. For more information or to schedule an interview, contact Kristin Mullani at (281) 240-3111 or info(at)veinlite(dot)com

 

SOURCE TransLite LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store